S-1: Ontrak Seeks to Register Shares for Warrant Exercises Amidst Nasdaq Compliance Concerns
S-1 Filing
Ontrak files for registration of up to 51,622,216 shares of common stock issuable upon the exercise of outstanding warrants, as the company navigates Nasdaq listing requirements.
Summary
- Ontrak, Inc. has filed a registration statement on Form S-1 to register up to 51,622,216 shares of its common stock.
- These shares are issuable upon the exercise of outstanding warrants issued in a public offering on November 14, 2023.
- The company is currently not in compliance with Nasdaq's minimum bid price requirement and is appealing a potential delisting.
- The filing includes a combined prospectus to update information from a previous registration statement (File No. 333-273029) related to the same warrants.
- The exercise price of the Public Offering Warrants is currently $0.3442 per share.
- The company intends to use the proceeds from the exercise of the warrants for general corporate purposes, including working capital.
- Acuitas Group Holdings, LLC owns approximately 61% of Ontrak's outstanding common stock and beneficially owns approximately 93% of the common stock.
Sentiment
Score: 4
Explanation: The document presents a mixed sentiment. While there's potential for capital influx through warrant exercises, the Nasdaq compliance issues and customer attrition raise concerns. The high ownership concentration also adds a layer of complexity.
Positives
- The potential exercise of warrants could provide the company with $17.9 million in proceeds for general corporate purposes.
- The company is taking steps to appeal the Nasdaq delisting notice and regain compliance with listing requirements.
- The company has implemented cost-saving measures through restructuring plans and workforce reductions.
Negatives
- The company is not currently in compliance with Nasdaq's minimum bid price requirement, leading to a potential delisting.
- A significant portion of the company's stock is controlled by Acuitas Group Holdings, LLC, potentially influencing company decisions.
- The company has experienced customer notifications of service termination, impacting revenue.
- The company has incurred significant losses since its inception and may be unable to obtain additional funds before it achieves positive cash flows.
Risks
- The company may not be able to regain compliance with Nasdaq listing standards, leading to delisting and adverse consequences.
- The concentration of ownership by Acuitas Group Holdings, LLC could lead to decisions that do not align with the interests of all stockholders.
- The company's reliance on a few large customers poses a risk if those customers terminate services.
- The company's common stock may be volatile.
- The company may not be able to generate sufficient cash flow or raise adequate financing to grow or scale its business or to fund its operations.
Future Outlook
The company intends to present its views to the Nasdaq Hearings Panel concerning its eligibility for an additional 180-calendar day period to regain compliance with the Minimum Bid Price Rule and its plans for regaining compliance, which would include implementing a reverse stock split if necessary.
Industry Context
The document does not provide specific details on how this announcement relates to broader industry trends or competitors beyond its focus on behavioral healthcare solutions.
Legal Proceedings
- The company is involved in various securities class actions and purported stockholder derivative complaints.
- The company has incurred legal costs related to the SEC/Department of Justice (the DOJ) investigation of its former Chief Executive Officer and Chairman of the Board of Directors.
Related Party Transactions
- The company has entered into multiple agreements and amendments with Acuitas Capital LLC, involving notes, warrants, and other securities.
- The company issued Private Placement Securities to Humanitario Capital LLC, an affiliate of Acuitas Capital.
Stakeholder Impact
- Shareholders face potential dilution from the exercise of warrants and the issuance of new securities.
- Employees have been affected by multiple restructuring plans and workforce reductions.
- Customers may experience changes in service as the company adjusts its business model.
- The company's ability to meet its obligations to creditors depends on its financial performance and ability to raise capital.
Next Steps
- The company will present its case to the Nasdaq Hearings Panel to appeal the delisting notice.
- The company intends to seek stockholder approval for certain actions related to the Sixth Amendment to the Keep Well Agreement.
- The company intends to file with the SEC a preliminary information statement related to the Stockholder Approval, and to thereafter file a definitive information statement with the SEC related to the Stockholder Approval and mail the same to the Company’s stockholders in accordance with SEC rules.
Key Dates
| Date | Description |
|---|---|
| September 29, 2003 | Ontrak was incorporated in the State of Delaware. |
| November 9, 2023 | The November 2023 Registration Statement was declared effective by the SEC. |
| November 10, 2023 | Date of the prospectus for the public offering warrants. |
| November 14, 2023 | Date of the public offering in which the warrants were issued. |
| October 13, 2023 | Ontrak received a letter from Nasdaq indicating non-compliance with the Minimum Bid Price Rule. |
| April 10, 2024 | Original deadline to regain compliance with Nasdaq's Minimum Bid Price Rule. |
| April 11, 2024 | Ontrak received a letter from Nasdaq notifying them that they had not regained compliance with the Minimum Bid Price Rule. |
| April 16, 2024 | The closing price of Ontrak's common stock was $0.46 per share. |
| April 19, 2024 | Date of the S-1 filing. |
| June 20, 2027 | Date related to anti-dilution provisions of the Public Offering Warrants. |
Keywords
warrants, common stock, Ontrak, Nasdaq, delisting, Acuitas, offering, compliance, exercise price, registration
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.